🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label extension study to Study 200622.In this study subject...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-11-13
Trial ID
NCT03306043
Treatments Being Tested
This is a multi-centre, placebo-controlled, double-blind, parallel-group st...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-11
Trial ID
NCT02281318
Treatments Being Tested
The purpose of the MEMORY trial is to compare the effects of mepolizumab wi...
Status
Terminated
Location
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Pneumologie
Start Date
2015-11-17
Trial ID
NCT02594332
Treatments Being Tested
This is an exploratory study designed to generate preliminary data in evalu...
Status
Completed
Location
Mayo Clinic in Florida
Start Date
2019-07-30
Trial ID
NCT03494881
Treatments Being Tested
Mepolizumab is a humanized monoclonal antibody. In conditions where eosinop...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-03-07
Trial ID
NCT02836496
Hypereosinophilic syndrome (HES) is a rare disease with broad clinical sign...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-03-23
Trial ID
NCT00086658
Treatments Being Tested
This study is designed to assess pharmacokinetics and pharmacodynamics of m...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2020-02-17
Trial ID
NCT04183192
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389
This study aims to investigate the efficacy and safety of depemokimab compa...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2022-07-14
Trial ID
NCT05263934
Treatments Being Tested
This is a randomised, double-blind, placebo-controlled, parallel-group, mul...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10
Trial ID
NCT01691508
Treatments Being Tested